An exploratory analysis of comparative plasma metabolomic and lipidomic profiling in salt-sensitive and salt-resistant individuals from The Dietary Approaches to Stop Hypertension Sodium Trial
Open Access
- 17 May 2021
- journal article
- research article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 39 (10) , 1972-1981
Abstract
Objective: This study conducted exploratory metabolomic and lipidomic profiling of plasma samples from the DASH (Dietary Approaches to Stop Hypertension) Sodium Trial to identify unique plasma biomarkers to identify salt-sensitive versus salt-resistant participants. Methods: Utilizing plasma samples from the DASH-Sodium Trial, we conducted untargeted metabolomic and lipidomic profiling on plasma from salt-sensitive and salt-resistant DASH-Sodium Trial participants. Study 1 analyzed plasma from 106 salt-sensitive and 85 salt-resistant participants obtained during screening when participants consumed their regular diet. Study 2 examined paired within-participant plasma samples in 20 salt-sensitive and 20 salt-resistant participants during a high-salt and low-salt dietary intervention. To investigate differences in metabolites or lipidomes that could discriminate between salt-sensitive and salt-resistant participants or the response to a dietary sodium intervention Principal Component Analysis and Orthogonal Partial Least Square Discriminant Analysis was conducted. Differential expression analysis was performed to validate observed variance and to determine the statistical significance. Results: Differential expression analysis between salt-sensitive and salt-resistant participants at screening revealed no difference in plasma metabolites or lipidomes. In contrast, three annotated plasma metabolites, tocopherol alpha, 2-ketoisocaproic acid, and citramalic acid, differed significantly between high-sodium and low-sodium dietary interventions in salt-sensitive participants. Conclusion: In DASH-Sodium Trial participants on a regular diet, plasma metabolomic or lipidomic signatures were not different between salt-sensitive and salt-resistant participants. High-sodium intake was associated with changes in specific circulating metabolites in salt-sensitive participants. Further studies are needed to validate the identified metabolites as potential biomarkers that are associated with the salt sensitivity of blood pressure.Keywords
This publication has 41 references indexed in Scilit:
- New evidence relating to the health impact of reducing salt intakeNutrition, Metabolism and Cardiovascular Diseases, 2011
- The Importance of Population-Wide Sodium Reduction as a Means to Prevent Cardiovascular Disease and StrokeCirculation, 2011
- Salt sensitivity is associated with insulin resistance, sympathetic overactivity, and decreased suppression of circulating renin activity in lean patients with essential hypertensionThe American Journal of Clinical Nutrition, 2010
- Defining and Setting National Goals for Cardiovascular Health Promotion and Disease ReductionCirculation, 2010
- Top-Down Lipidomics Reveals Ether Lipid Deficiency in Blood Plasma of Hypertensive PatientsPLOS ONE, 2009
- Human metabolic phenotype diversity and its association with diet and blood pressureNature, 2008
- Quality control for plant metabolomics: reporting MSI‐compliant studiesThe Plant Journal, 2008
- Effect of Dietary Sodium Intake on Blood LipidsHypertension, 2004
- Prevention of Hypertension and Renal Dysfunction in Dahl Rats by α-TocopherolJournal of Cardiovascular Pharmacology, 2003
- The DASH Diet, Sodium Intake and Blood Pressure Trial (DASH-Sodium)Journal of the American Dietetic Association, 1999